“…(2S,4R)-4-Tosyloxi-N-Boc-proline, [22] tert-butyl (R)-N-(tert-butyloxycarbonyl)pyroglutamate [as it was described for (S)-isomer], [34] tert-butyl (2R,4R)-(N-tert-butyloxycarbonyl)-4-allylpyroglutamate [as it was described for (2S,4S)-isomer], [35] methyl (2S,4R)-(N-tertbutyloxycarbonyl)-4-hydroxyprolinate, [46] methyl (2S,4RS)-(N-tert-butyloxycarbonyl)-4iodopro-linate, [47] (2S,4R)-(N-tert-butyloxycarbonyl)-4-hydroxyproline, [53] , (2S,4R)-(N-tertbutyloxy-carbonyl)-4-mesyloxyprolinol, [57] (2S,4R)-(N-tert-butyloxycarbonyl)-4-hydroxyprolixnol tert-butyldimetylsilyl ester, [62] adduct of (2S,4R)-4-hydroxyproline and pivalic aldehyde, [64] rac-(trans-2'-nitrocyclopropyl)methanol, [84] (1,1-dideutero)ethyltriphenylphosphonium bromide, [72] (R)-allo-threonine, [75] (4R)-phenyloxazolidinone-2, [80] (4R)-4-phenyl-3-(3'phenylbutyryl)oxazo-lidinone-2, [79] (4R,3'S)-4-phenyl-3-(3'-phenylbutyryl)oxazolidinone-2 [as it was described for (4S,3'R)-isomer], [81] 1,1,3,3-tetramethyl guanidinium azide, [136] rac-βmethylphenylalanine, [137] (2S,3R)-β-methylphenylalanine, [79] (S) and (R) Belokon's chiral glycine equivalents, [86] (4R)-4-isopropyl-1,3-trans-(2'-nitrocyclopropyl)carbonyloxazolidinones-2, [14] trans-(2'-nitrocyclopro-pyl)methyl iodide, [80] 1-methoxysuccinimide, [97] 2-amino-6chloropyridine, [99] 2-acetamido-6-chloropyridine, [101] 2,6-dichloropyridine-N-oxide, [102] 9flourenylmethyl (S)-(N-tert-butyloxycarbonyl)phenylalaninate, [105] 2-acetamino-6-aminopyridine, [107] (S)-(2-nitrophenyl)sulfenylproline, [116] (S)-(2-nitrophenyl)sulfenylisoleucine, [116] methyl (N-tert-butyloxycarbonyl)-isoleucyl-prolinate, [117] p-nitrobenzyl (R)-allo-(N-tert-butyloxycarbonyl)threoninate [as it was described for (S)-threo-isomer], [120] (2S,3R)-(N-9-fluorenylmethyloxycarbonyl)-β-methylphenylalanine, …”